previous compound ID: 227 next compound
InChIKey: BGRJTUBHPOOWDU-UHFFFAOYSA-N
SMILES: CCN1CCCC1CNC(=O)C2=C(C=CC(=C2)S(=O)(=O)N)OC

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"J Goepp" "JW Hanrahan" "B Kus" "GW Carlile" "D Rotin" "SD Macknight" "DY Thomas" "E Matthes" "R Robert" "J Liao"

chemical graph of compound 227





CID is 5355
synonyms found at PubChem are:
sulpiride, 15676-16-1, Sulpyrid, Sulpirid, Aiglonyl, Dolmatil, Dogmatil, Guastil, Mirbanil, Misulvan, Sursumid, Abilit, Dobren, Eglonyl, Meresa, Miradol, Neogama, Omperan, Splotin, (+/-)-Sulpiride, Coolspan, Dogmatyl, Psicocen, Pyrkappl, Sernevin, (RS)-(+/-)-sulpiride, Calmoflorine, Alimoral, Championyl, Darleton, Desmenat, Eusulpid, Fardalan, Isnamide, Kylistro, Lisopiride, Mariastel, Norestran, Ozoderpin, Stamonevrol, Sulpirida, Sulpiridum, Sulpitil, Zemorcon, Dresent, Eglonil, Enimon, Equilid, Fidelan, Normum, Nufarol, Omiryl, Restful, Suprium, Valirem, Sulpiridum [INN-Latin], Sulpirida [INN-Spanish], Synedil, N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide, Pyrikappl, dl-sulpiride, RD 1403, Levosulpiridum [INN-Latin], Levosulpirida [INN-Spanish], CCRIS 4248, R.D. 1403, Sulpiride [USAN:INN:BAN:JAN], CHEMBL26, EINECS 239-753-7, N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, Levosulpiride [INN], N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide, BRN 0494008, 5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide, Sulperide, Sulpor, Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, C15H23N3O4S, CHEBI:32168, BGRJTUBHPOOWDU-UHFFFAOYSA-N, Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, o-Anisamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-, Levosulpirida, Levosulpiridum, Levobren, Sulpride, Sulpiride-R, Dogmatyl (TN), Magnetic resonance imaging sulpiride, N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide, (+)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide, 5-(Aminosufonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, SMR000038923, SULPIRIDE,(+), SR-01000075402, (y)-Sulpiride, Sulpiride, SLP, (plusmn)-sulpiride, RV-12309, (?)-Sulpiride, Prestwick_431, (+-)-sulpiride, CAS-15676-16-1, R. D. 1403, S 8010, PubChem17241, (.+/-.)-Sulpiride, Prestwick0_000056, Prestwick1_000056, Prestwick2_000056, Prestwick3_000056, SULPIRIDE,(-), Biomol-NT_000037, Biomol-NT_000162, SCHEMBL8421, DSSTox_CID_22574, DSSTox_RID_80050, DSSTox_GSID_42574, Lopac0_001050, Oprea1_602476, BSPBio_000211, (RS)-(A+/-)-Sulpiride, 5-22-08-00105 (Beilstein Handbook Reference), MLS000069434, MLS001306443, DivK1c_000278, SPBio_002132, AC1L1K62, BPBio1_000233, BPBio1_000463, BPBio1_001255, CCRIS-4248, GTPL5501, Sulpiride (JP17/USAN/INN), DTXSID1042574, BDBM11638, CTK8F2082, HMS500N20, KBio1_000278, KS-00000YBQ, Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-, MolPort-002-070-475, NINDS_000278, o-ANISAMIDE, N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-SULFAMOYL-, (S)-(-)-, Sulpiride 1.0 mg/ml in Methanol, HMS1568K13, HMS2095K13, HMS2231K07, HMS3263A22, HMS3266P12, HMS3371P16, HMS3372O01, HMS3393A08, HMS3651G12, HMS3712K13, BCP04500, BCP13871, HY-B1019, ( inverted question mark)-Sulpiride, Tox21_302205, Tox21_501050, BG0324, MFCD00055061, s4655, STK368596, AKOS004912732, AN-1017, AN-1019, API0003468, CCG-205127, CS-4534, DB00391, LP01050, MCULE-7506797476, IDI1_000278, NCGC00015966-03, NCGC00015966-04, NCGC00015966-05, NCGC00015966-06, NCGC00015966-07, NCGC00015966-08, NCGC00024852-02, NCGC00024852-03, NCGC00024852-04, NCGC00024852-05, NCGC00255813-01, NCGC00261735-01, AC-12181, LS-20058, LS-20059, AB0105833, KB-295026, EU-0001755, EU-0101050, FT-0652244, S0501, D01226, J10067, 676S161, L000579, I06-0054, SR-01000075402-2, SR-01000075402-3, SR-01000075402-6, BRD-A55272860-001-03-9, BRD-A55272860-001-04-7, BRD-A55272860-001-08-8, Z84655412, Sulpiride, British Pharmacopoeia (BP) Reference Standard, 1-ethyl-2-(2-methoxy-5-sulfamoylbenzamidomethyl)pyrrolidine, Sulpiride, European Pharmacopoeia (EP) Reference Standard, N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide, N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoyl-benzamide, N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide, (+/-)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide, (+/-)-N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide, 5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-benzamide, Benzamide,5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-, (+/-)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, (RS)-(+/-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide, 5-(Aminosulfonyl)-N-[(1-ethyl-2- pyrrolidinyl)methyl]-2-methoxy- benzamide, Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-, ( inverted question mark)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide